Kinases downstream of ERK, including p90 ribosomal S6 kinase (RSK), which is involved in transcription and translation mediated via the Y-box binding protein 1, also result in improved tumor cell survival despite treatment with chemotherapy [98]. The gene discussed is MAPK1; the disease is neoplasm.